← All indications
Body Weight Changes
A clinical manifestation consisting of alterations in an individual's weight from his or her norm.
Subtype terms (3)
More specific conditions that are subtypes of Body Weight Changes in the MeSH hierarchy.
- Body-Weight Trajectory
4 drugs (2 approved, 2 experimental)
- Weight Gain
50 drugs (37 approved, 13 experimental)
- Weight Loss
107 drugs (56 approved, 51 experimental)
Drugs by status
Phase 4 trials (13)
Phase 3 trials (4)
Phase 2 trials (6)
Phase 1 trials (2)
Other trials (33)
- maltodextrin
- ethambutol
- fiber
- l-glutamine
- calcium
- rifampin
- hydroxymethylbutyrate
- whey protein
- human milk
- oyster mushroom
- peanut
- pyrazinamide
- ubiquinol
- glucose
- gynostemma pentaphyllum
- multivitamins
- isoniazid
- soybean
- clove
- sodium bicarbonate
- turmeric
- omega-3 fatty acids
- fish oil
- fulvate
- saffron
- white kidney bean
- maqui berry
- sesame lignans
- hesperidin
- arginine
- +3 more
Organizations
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (9)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (16)
- Supplement Formulators, Inc.
- Aarhus University
- DLR German Aerospace Center
- New York Obesity and Nutrition Research Center
- Justus Liebig University Giessen
- University of Copenhagen
- University of Turku
- University of Trieste
- University of Turin
- German Aerospace Centre
- Arla Foods
- PepsiCo
- Indonesian Directorate General of Higher Education
- European Space Agency
- Nupo A/S, Denmark
- LIfe Extension